WHITNEY WILKINSON: Open Payments
NPI 1225545585 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 26 payments from 8 companies in 2025. Trend: 2023 $330 · 2024 $474 · 2025 $556
Food & beverage: $456Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Sumitomo Pharma America, Inc. | 4 | $59 |
| Novocure Inc. | 2 | $50 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Medline Industries LP | 1 | $16 |
Products named: ERLEADA, Xofigo, PLUVICTO, ORGOVYX, Optune Gio, PYLARIFY, Xtandi, Nubeqa.
Industry payments across MS — which companies pay providers there.
